Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Why Is CVS Health (CVS) Up 8.3% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Benjamin Rains headshot

3 Cheap Stocks Under $10 to Buy Now for Coronavirus Reopening Rally

Today we look at three "cheap" stocks trading under $10 a share that might be worth buying as the market continues to march higher on coronavirus reopening optimism and more...

Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply

Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply

Sumit Singh headshot

4 Stocks That Flaunt an Impressive Interest Coverage Ratio

Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.

Molina Healthcare's New Deal to Boost Its Medicaid Business

Molina Healthcare's (MOH) new agreement intends to efficiently serve its Medicaid members, which, in turn, will likely boost its market presence.

Zacks.com headshot

Consumer Confidence Sees Revival in May: Here's What it Means

It seems that consumers' confidence got restored in May as lockdowns were eased and businesses gradually reopened. Government stimulus helped companies weather the coronavirus crisis and improve their customer sentiments.

Are Investors Undervaluing CVS Health (CVS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cigna Adds Capabilities to Expand Its Virtual Care Service

Cigna (CI) has added a private messaging application to better serve its members amid COVID-19 breakout.

The Zacks Analyst Blog Highlights: NVIDIA, Coca-Cola, PetroChina, CVS Health and Zoom Video Communications

The Zacks Analyst Blog Highlights: NVIDIA, Coca-Cola, PetroChina, CVS Health and Zoom Video Communications

Sheraz Mian headshot

Q1 Scorecard and Research Reports for NVIDIA, Coca-Cola, PetroChina & Others

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Coca-Cola (KO) and PetroChina (PTR).

Zacks.com headshot

Cigna (CI) Dispenses Digital Services to Fight Coronavirus

Cigna (CI) offers digital solutions to facilitate real-time support to its customers for tracking coronavirus symptoms.

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - May 11, 2020

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?

Stock Market News for May 7, 2020

Benchmarks closed mixed on Wednesday as data showed that private payroll had furloughed more than 20 million workers in April, highlighting the economic impact of the pandemic.

CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate

Within CVS Health's (CVS) Retail/LTC, the coronavirus pandemic results in greater use of 90-day prescriptions and early refills of maintenance medications in the quarter.

CVS Health (CVS) Q1 Earnings and Revenues Surpass Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 17.18% and 5.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights: Microsoft, CVS, Boeing, Facebook and Sherwin-Williams

The Zacks Analyst Blog Highlights: Microsoft, CVS, Boeing, Facebook and Sherwin-Williams

What's in the Cards for CVS Health (CVS) in Q1 Earnings?

We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.

Sheraz Mian headshot

Top Research Reports for Microsoft, CVS Health & Boeing

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), CVS Health (CVS) and Boeing (BA).

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $63.43, moving +0.3% from the previous trading session.

CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - April 29, 2020

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed the most recent trading day at $61.31, moving +1.59% from the previous trading session.

How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - April 23, 2020

The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Rite Aid (RAD) Expands Coronavirus Testing Site to Virginia

Rite Aid (RAD) is aggressively expanding COVID-19 testing locations, marked by the opening of its 25th site at Richmond, VA, to help curb the effects of the pandemic.

Rite Aid's (RAD) Q4 Loss Wider Than Expected, Sales Rise Y/Y

Strong revenues at pharmacy services and retail pharmacy segments aided Rite Aid's (RAD) Q4 results. Further, management issued FY21 view, which reflects no COVID-19 impacts.